SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria

SMARCA4/2 loss in ovarian and lung cancers is associated with chemotherapy resistance. Here, the authors show that SMARCA4/2 deficiency in cancer cells reduces the expression of the ER-Ca2+ channel IP3R3 and subsequently calcium transfer to the mitochondria, which inhibits apoptotic cell death.

Guardado en:
Detalles Bibliográficos
Autores principales: Yibo Xue, Jordan L. Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson, Brian Meehan, Leora Witkowski, Amber Yasmeen, Tunde Golenar, Mackenzie Coatham, Geneviève Morin, Anie Monast, Virginie Pilon, Pierre Olivier Fiset, Sungmi Jung, Anne V. Gonzalez, Sophie Camilleri-Broet, Lili Fu, Lynne-Marie Postovit, Jonathan Spicer, Walter H. Gotlieb, Marie-Christine Guiot, Janusz Rak, Morag Park, William Lockwood, William D. Foulkes, Julien Prudent, Sidong Huang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/bf575d4233b14e5f997658655553d914
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf575d4233b14e5f997658655553d914
record_format dspace
spelling oai:doaj.org-article:bf575d4233b14e5f997658655553d9142021-12-02T18:50:04ZSMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria10.1038/s41467-021-25260-92041-1723https://doaj.org/article/bf575d4233b14e5f997658655553d9142021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25260-9https://doaj.org/toc/2041-1723SMARCA4/2 loss in ovarian and lung cancers is associated with chemotherapy resistance. Here, the authors show that SMARCA4/2 deficiency in cancer cells reduces the expression of the ER-Ca2+ channel IP3R3 and subsequently calcium transfer to the mitochondria, which inhibits apoptotic cell death.Yibo XueJordan L. MorrisKangning YangZheng FuXianbing ZhuFraser JohnsonBrian MeehanLeora WitkowskiAmber YasmeenTunde GolenarMackenzie CoathamGeneviève MorinAnie MonastVirginie PilonPierre Olivier FisetSungmi JungAnne V. GonzalezSophie Camilleri-BroetLili FuLynne-Marie PostovitJonathan SpicerWalter H. GotliebMarie-Christine GuiotJanusz RakMorag ParkWilliam LockwoodWilliam D. FoulkesJulien PrudentSidong HuangNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yibo Xue
Jordan L. Morris
Kangning Yang
Zheng Fu
Xianbing Zhu
Fraser Johnson
Brian Meehan
Leora Witkowski
Amber Yasmeen
Tunde Golenar
Mackenzie Coatham
Geneviève Morin
Anie Monast
Virginie Pilon
Pierre Olivier Fiset
Sungmi Jung
Anne V. Gonzalez
Sophie Camilleri-Broet
Lili Fu
Lynne-Marie Postovit
Jonathan Spicer
Walter H. Gotlieb
Marie-Christine Guiot
Janusz Rak
Morag Park
William Lockwood
William D. Foulkes
Julien Prudent
Sidong Huang
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
description SMARCA4/2 loss in ovarian and lung cancers is associated with chemotherapy resistance. Here, the authors show that SMARCA4/2 deficiency in cancer cells reduces the expression of the ER-Ca2+ channel IP3R3 and subsequently calcium transfer to the mitochondria, which inhibits apoptotic cell death.
format article
author Yibo Xue
Jordan L. Morris
Kangning Yang
Zheng Fu
Xianbing Zhu
Fraser Johnson
Brian Meehan
Leora Witkowski
Amber Yasmeen
Tunde Golenar
Mackenzie Coatham
Geneviève Morin
Anie Monast
Virginie Pilon
Pierre Olivier Fiset
Sungmi Jung
Anne V. Gonzalez
Sophie Camilleri-Broet
Lili Fu
Lynne-Marie Postovit
Jonathan Spicer
Walter H. Gotlieb
Marie-Christine Guiot
Janusz Rak
Morag Park
William Lockwood
William D. Foulkes
Julien Prudent
Sidong Huang
author_facet Yibo Xue
Jordan L. Morris
Kangning Yang
Zheng Fu
Xianbing Zhu
Fraser Johnson
Brian Meehan
Leora Witkowski
Amber Yasmeen
Tunde Golenar
Mackenzie Coatham
Geneviève Morin
Anie Monast
Virginie Pilon
Pierre Olivier Fiset
Sungmi Jung
Anne V. Gonzalez
Sophie Camilleri-Broet
Lili Fu
Lynne-Marie Postovit
Jonathan Spicer
Walter H. Gotlieb
Marie-Christine Guiot
Janusz Rak
Morag Park
William Lockwood
William D. Foulkes
Julien Prudent
Sidong Huang
author_sort Yibo Xue
title SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
title_short SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
title_full SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
title_fullStr SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
title_full_unstemmed SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
title_sort smarca4/2 loss inhibits chemotherapy-induced apoptosis by restricting ip3r3-mediated ca2+ flux to mitochondria
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bf575d4233b14e5f997658655553d914
work_keys_str_mv AT yiboxue smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT jordanlmorris smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT kangningyang smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT zhengfu smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT xianbingzhu smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT fraserjohnson smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT brianmeehan smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT leorawitkowski smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT amberyasmeen smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT tundegolenar smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT mackenziecoatham smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT genevievemorin smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT aniemonast smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT virginiepilon smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT pierreolivierfiset smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT sungmijung smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT annevgonzalez smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT sophiecamilleribroet smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT lilifu smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT lynnemariepostovit smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT jonathanspicer smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT walterhgotlieb smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT mariechristineguiot smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT januszrak smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT moragpark smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT williamlockwood smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT williamdfoulkes smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT julienprudent smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT sidonghuang smarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
_version_ 1718377529366020096